Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia

医学 急性早幼粒细胞白血病 内科学 凝血病 D-二聚体 胃肠病学 血栓形成 风险因素 并发症 外科 生物化学 基因 化学 维甲酸
作者
Mengyu Xiao,Pan Zhou,Yan‐Hui Liu,Shengjie Wei,Dan Li,Weiya Li,Xiaona Niu,Junwei Niu,Yinyin Zhang,Weijie Cao,Bing Liu,Xiaojiao Wang,Yanliang Bai,Kai Sun
出处
期刊:Thrombosis Research [Elsevier BV]
卷期号:210: 33-41 被引量:8
标识
DOI:10.1016/j.thromres.2021.12.020
摘要

Acute promyelocytic leukemia (APL) is often accompanied by potentially fatal coagulopathy, especially in high-risk APL. Bleeding, particularly severe bleeding is the leading cause of early death (ED). Meanwhile, thrombosis, the other major coagulopathic complication, is being increasingly recognized. However, predictors of thrombohemorrhagic disorders are still not well investigated.In this study, we retrospectively studied 83 patients with high-risk APL and categorized them into severe bleeding, thrombosis and no evident events groups.Severe bleeding was observed in 15 patients, nearly half of whom died of hemorrhage, while thrombosis was observed in 12 patients. Risk factor analysis showed that high WBC (>58.76 × 109/L) (p = 0.001) and prolonged PT (>17.7 s) (p = 0.015) could be independent predictors for severe bleeding, while high WBC/D-dimer>5.12 (p = 0.002) and low D-dimer/FIB<5.14 (p = 0.03) could be independent predictors for thrombosis in high-risk APL patients. Moreover, there are significant differences in WBC/D-dimer and D-dimer/FIB between DIC and Non-DIC groups (p < 0.001). Notably, we found that the WBC/D-dimer was dramatically higher in the thrombotic group than in the other two groups at the time of admission or during the first week of induction therapy.High WBC and prolonged PT could predict severe bleeding in high-risk APL patients, while high WBC/D-dimer and low D-dimer/FIB could be independent predictors for thrombosis. For high-risk APL, WBC/D-dimer and D-dimer/FIB are also beneficial in the diagnosis of DIC. WBC/D-dimer might help early identification of thrombosis at the time of admission or during the first week of induction therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热情松鼠完成签到,获得积分10
1秒前
1秒前
1秒前
情怀应助陈陈采纳,获得10
2秒前
万能图书馆应助蔡佰航采纳,获得10
2秒前
呓语发布了新的文献求助10
2秒前
xingfangshu发布了新的文献求助10
3秒前
BJYX完成签到,获得积分10
3秒前
无语的稀完成签到,获得积分10
3秒前
小马甲应助倩倩采纳,获得10
3秒前
sily完成签到,获得积分10
4秒前
iNk应助神华采纳,获得20
4秒前
Twilight完成签到,获得积分10
5秒前
小小小完成签到,获得积分10
5秒前
尊嘟假嘟应助wuhuhu采纳,获得30
5秒前
pzt完成签到,获得积分10
5秒前
Sivona完成签到,获得积分10
6秒前
爆米花应助小筱采纳,获得10
6秒前
7秒前
笨笨火龙果完成签到,获得积分10
7秒前
机智向松完成签到,获得积分10
7秒前
无花果应助赵sir采纳,获得10
7秒前
7秒前
噼里啪啦发布了新的文献求助10
7秒前
今后应助YU采纳,获得10
8秒前
灯灯完成签到,获得积分10
8秒前
飞奔的晶粒完成签到,获得积分10
9秒前
Yangyang完成签到,获得积分10
9秒前
1122发布了新的文献求助10
9秒前
空白格完成签到 ,获得积分10
9秒前
9秒前
10秒前
10秒前
疯狂的安容完成签到,获得积分10
10秒前
ZephyrZY完成签到,获得积分10
11秒前
乐乐应助spy采纳,获得10
11秒前
11秒前
健壮映波应助嘻嘻嘻采纳,获得10
11秒前
害羞的不尤完成签到,获得积分20
12秒前
12秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6534989
求助须知:如何正确求助?哪些是违规求助? 8328337
关于积分的说明 17842681
捐赠科研通 5636787
什么是DOI,文献DOI怎么找? 2934706
邀请新用户注册赠送积分活动 1910870
关于科研通互助平台的介绍 1769279